Myomo (MYO) Cash & Equivalents (2016 - 2025)

Myomo (MYO) has 10 years of Cash & Equivalents data on file, last reported at $14.7 million in Q4 2025.

• Quarterly Cash & Equivalents fell 40.57% year-over-year to $14.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.7 million (down 40.57% YoY) and the FY2025 annual result came in at $14.7 million, down 40.57% from the prior year.
• Cash & Equivalents advanced to $14.7 million in Q4 2025, from $12.9 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $24.7 million in Q4 2024 to a low of $5.3 million in Q4 2022.
• A 5-year average of $11.7 million and a median of $11.4 million in 2021 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 65.56% — and 2025, when it soared 271.11%.
• Tracing MYO's Cash & Equivalents over 5 years: stood at $15.5 million in 2021, then plunged by 65.56% to $5.3 million in 2022, then climbed by 28.53% to $6.9 million in 2023, then jumped by 260.16% to $24.7 million in 2024, then sank by 40.57% to $14.7 million in 2025.
• The last three Cash & Equivalents figures came in at $14.7 million (Q4 2025), $12.9 million (Q3 2025), and $15.5 million (Q2 2025), per Business Quant data.